These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17223319)

  • 1. Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues.
    Cornaglia G; Akova M; Amicosante G; Cantón R; Cauda R; Docquier JD; Edelstein M; Frère JM; Fuzi M; Galleni M; Giamarellou H; Gniadkowski M; Koncan R; Libisch B; Luzzaro F; Miriagou V; Navarro F; Nordmann P; Pagani L; Peixe L; Poirel L; Souli M; Tacconelli E; Vatopoulos A; Rossolini GM;
    Int J Antimicrob Agents; 2007 Apr; 29(4):380-8. PubMed ID: 17223319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallo-beta-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?
    Maltezou HC
    Int J Antimicrob Agents; 2009 May; 33(5):405.e1-7. PubMed ID: 19095416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy.
    Rossolini GM; Luzzaro F; Migliavacca R; Mugnaioli C; Pini B; De Luca F; Perilli M; Pollini S; Spalla M; Amicosante G; Toniolo A; Pagani L
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4023-9. PubMed ID: 18809945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance in Gram-negative bacteria that produce extended-spectrum beta-lactamases (ESBLs).
    Giamarellou H
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():1-16. PubMed ID: 15953019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired metallo-beta-lactamases: an increasing clinical threat.
    Rossolini GM
    Clin Infect Dis; 2005 Dec; 41(11):1557-8. PubMed ID: 16267726
    [No Abstract]   [Full Text] [Related]  

  • 6. Emerging resistance in Gram-negative pathogens and implications for clinical practice.
    Cantón R; Lumb J
    Future Microbiol; 2011 Jan; 6(1):19-22. PubMed ID: 21162632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
    Walsh TR
    Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():2-9. PubMed ID: 16209700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.
    Rossolini GM; Mantengoli E; Docquier JD; Musmanno RA; Coratza G
    New Microbiol; 2007 Jul; 30(3):332-9. PubMed ID: 17802921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy.
    Bush K
    Clin Infect Dis; 2001 Apr; 32(7):1085-9. PubMed ID: 11264037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues.
    Miriagou V; Cornaglia G; Edelstein M; Galani I; Giske CG; Gniadkowski M; Malamou-Lada E; Martinez-Martinez L; Navarro F; Nordmann P; Peixe L; Pournaras S; Rossolini GM; Tsakris A; Vatopoulos A; Cantón R
    Clin Microbiol Infect; 2010 Feb; 16(2):112-22. PubMed ID: 20085605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
    Hrabák J
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance among and therapeutic options against gram-negative pathogens.
    Rahal JJ
    Clin Infect Dis; 2009 Aug; 49 Suppl 1():S4-S10. PubMed ID: 19619021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory.
    Franklin C; Liolios L; Peleg AY
    J Clin Microbiol; 2006 Sep; 44(9):3139-44. PubMed ID: 16954239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current challenges in antimicrobial chemotherapy: the impact of extended-spectrum beta-lactamases and metallo-beta-lactamases on the treatment of resistant Gram-negative pathogens.
    Helfand MS; Bonomo RA
    Curr Opin Pharmacol; 2005 Oct; 5(5):452-8. PubMed ID: 16084766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-fermentative Gram-negative bacteria.
    Enoch DA; Birkett CI; Ludlam HA
    Int J Antimicrob Agents; 2007 May; 29 Suppl 3():S33-41. PubMed ID: 17659210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current state of multidrug-resistant gram-negative bacilli in North America.
    Nicasio AM; Kuti JL; Nicolau DP
    Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.
    Carmeli Y; Akova M; Cornaglia G; Daikos GL; Garau J; Harbarth S; Rossolini GM; Souli M; Giamarellou H
    Clin Microbiol Infect; 2010 Feb; 16(2):102-11. PubMed ID: 20085604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.